Tilray Brands (TLRY) Accounts Payables (2017 - 2026)
Tilray Brands' (TLRY) quarterly Accounts Payables came in at $318.1 million in Q2 2026, up 35.17% YoY from $235.3 million in Q2 2025, and up 42.01% on a QoQ basis from $224.0 million in Q1 2026.
Tilray Brands (TLRY) Accounts Payables (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Accounts Payables data on file, last reported at $318.1 million in Q2 2026.
- Quarterly Accounts Payables rose 35.17% year-over-year to $318.1 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $318.1 million (up 35.17% YoY) and the FY2026 annual result came in at $318.1 million, up 35.17% from the prior year.
- Accounts Payables improved to $318.1 million in Q2 2026, from $224.0 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $318.1 million in Q2 2026 to a low of $137.1 million in Q1 2022.
- A 5-year average of $210.1 million and a median of $219.3 million in 2023 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables retreated 26.02% — and 2023, when it jumped 53.94%.
- Tracing TLRY's Accounts Payables over 5 years: stood at $162.9 million in 2022, then soared by 33.15% to $216.9 million in 2023, then rose by 2.2% to $221.7 million in 2024, then increased by 2.14% to $226.4 million in 2025, then jumped by 40.48% to $318.1 million in 2026.
- The last three Accounts Payables figures came in at $318.1 million (Q2 2026), $224.0 million (Q1 2026), and $226.4 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 356.00 Mn |
| 10 | Tilray Brands | 513.87 Mn | 279.24 Mn | 90.52 Mn | 318.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 318.09 Mn |
| Feb 28, 2026 | 224.00 Mn |
| Nov 30, 2025 | 226.42 Mn |
| Aug 31, 2025 | 230.91 Mn |
| May 31, 2025 | 235.32 Mn |
| Feb 28, 2025 | 216.57 Mn |
| Nov 30, 2024 | 221.67 Mn |
| Aug 31, 2024 | 236.15 Mn |
| May 31, 2024 | 241.96 Mn |
| Feb 29, 2024 | 209.76 Mn |
| Nov 30, 2023 | 216.90 Mn |
| Aug 31, 2023 | 238.08 Mn |
| May 31, 2023 | 190.68 Mn |
| Feb 28, 2023 | 163.42 Mn |
| Nov 30, 2022 | 162.90 Mn |
| Aug 31, 2022 | 154.66 Mn |
| May 31, 2022 | 157.43 Mn |
| Feb 28, 2022 | 137.09 Mn |
| Nov 30, 2021 | 168.30 Mn |
| Aug 31, 2021 | 190.21 Mn |